RE:RE:RE:RE:RE:RE:RE:2020 & 2021 CC comments on acquisitions and VA contracts Good points all If it's worth anything I share your irritation. All I can say is I keep looking at headcount patient growth and the trends in the financials and think we are going to do well
if you price the existing business the stock is about fairly priced at 27 PE. The issue is where the future growth will be whether it's acquisition or VA or whatever. The Royal bank called $20 plus for its upside target.
I take comfort in the number of analysts targeting over $14. The one recent adjustment was down a buck. Big deal.
I remember the $5 gains in two weeks - the days of short term gratification are over. For that we have Bestobe's sister.